Bio-Techne
TECH
TECH
561 hedge funds and large institutions have $17.8B invested in Bio-Techne in 2021 Q3 according to their latest regulatory filings, with 91 funds opening new positions, 199 increasing their positions, 177 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
561
Holders Change
+52
Holders Change %
+10.22%
% of All Funds
9.85%
Holding in Top 10
16
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+23.08%
% of All Funds
0.28%
New
91
Increased
199
Reduced
177
Closed
34
Calls
$36.3M
Puts
$43.8M
Net Calls
-$7.48M
Net Calls Change
+$57M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$307M |
| 2 |
State Street
Boston,
Massachusetts
|
+$154M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$83.6M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$74.1M |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$66.7M |
Top Sellers
| 1 |
BlackRock
New York
|
-$425M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$88.2M |
| 3 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$62.7M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$59M |
| 5 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
-$43M |
